Long Noncoding RNAs in Diffuse Large B-Cell Lymphoma: Current Advances and Perspectives

Por Huang, Xianbo, Qian, Wenbin, Ye, Xiujin
Publicado no Onco Targets Ther (2020)

Mechanisms of inhibiting human leukemia cell lines by serum of rats treated with compound banmao capsule

Por Li, Li, Zhu, Lixia, Zhu, Jingjing, Fan, Xiaofen, Ye, Xiujin
Publicado no Oncol Lett (2017)

γ-Catenin Overexpression in AML Patients May Promote Tumor Cell Survival via Activation of the Wnt/β-Catenin Axis

Por Qian, Jiejin, Huang, Xianbo, Zhang, Yinyin, Ye, Xiujin, Qian, Wenbin
Publicado no Onco Targets Ther (2020)

Shikonin overcomes drug resistance and induces necroptosis by regulating the miR-92a-1-5p/MLKL axis in chronic myeloid leukemia

Por Huang, Xianbo, Chen, Zhenzhen, Ni, Fan, Ye, Xiujin, Qian, Wenbin
Publicado no Aging (Albany NY) (2020)

Bypassing drug resistance by triggering necroptosis: recent advances in mechanisms and its therapeutic exploitation in leukemia

Por Huang, Xianbo, Xiao, Feng, Li, Yuan, Qian, Wenbin, Ding, Wei, Ye, Xiujin
Publicado no J Exp Clin Cancer Res (2018)

Adult Ph-positive acute lymphoblastic leukemia-current concepts in cytogenetic abnormalities and outcomes

Por Shi, Ting, Huang, Xianbo, Zhu, Lixia, Li, Xueying, Li, Li, Ye, Xiujin
Publicado no Am J Cancer Res (2020)

Prognostic significance of a normal karyotype in adult patients with BCR-ABL1-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era

Por Shi, Ting, Wang, Huanping, Xie, Mixue, Li, Xueying, Zhu, Lixia, Ye, Xiujin
Publicado no Clinics (Sao Paulo) (2020)

Profiling of microRNAs in AML cells following overexpression or silencing of the VEGF gene

Por Li, Li, Zhu, Lixia, Wang, Yungui, Zhou, De, Zhu, Jingjing, Xie, Wanzhuo, Ye, Xiujin
Publicado no Oncol Lett (2017)

The novel anticancer agent JNJ-26854165 is active in chronic myeloid leukemic cells with unmutated BCR/ABL and T315I mutant BCR/ABL through promoting proteosomal degradation of BCR...

Por You, Liangshun, Liu, Hui, Huang, Jian, Xie, Wanzhuo, Wei, Jueying, Ye, Xiujin, Qian, Wenbin
Publicado no Oncotarget (2016)

Novel homobarringtonie-containing therapy for the treatment of patients with primary acute myeloid leukemia that are resistant to conventional therapy

Por He, Jingsong, Li, Li, Zhu, Jingjing, Zheng, Weiyan, Wu, Wenjun, Zheng, Yanlong, Ye, Xiujin
Publicado no Oncol Lett (2017)

The molecular mechanisms underlying BCR/ABL degradation in chronic myeloid leukemia cells promoted by Beclin1-mediated autophagy

Por Huang, Xianbo, Li, Ying, Shou, Lihong, Li, Li, Chen, Zhenzhen, Ye, Xiujin, Qian, Wenbin
Publicado no Cancer Manag Res (2019)

Establishment and Application of Warning Scoring System for Early Intracranial Hemorrhage in Acute Non-promyelocytic Leukemia Patients

Por ZHANG Qiaolei, YE Xiujin, FANG Bingmu, JIANG Jinhong, LIU Yonghua, WANG Xiaoli, JIANG Yu, JIN Weimei, ZENG Yuxiao
Publicado em 2020-09-01

Increased Serum Level of Interleukin-10 Predicts Poor Survival and Early Recurrence in Patients With Peripheral T-Cell Lymphomas

Por Zhang, Yan, Zheng, Yanlong, Shou, Lihong, Shi, Yuanfei, Shen, Huafei, Zhu, Mingyu, Ye, Xiujin, Jin, Jie, Xie, Wanzhuo
Publicado no Front Oncol (2020)

Replacement of conventional doxorubicin by pegylated liposomal doxorubicin in standard RCHOP chemotherapy for elderly diffuse large B-Cell lymphoma: a retrospective study in China

Por Zhou, De, Li, Li, Bao, Changqian, Zhu, Jingjing, Zhu, Lixia, Yang, Xiudi, Zheng, Yanlong, Zhou, Meng, Luo, Xuxia, Xie, Wanzhuo, Ye, Xiujin
Publicado no Int J Clin Exp Med (2015)

HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants

Por Xie, Mixue, Jiang, Qi, Li, Li, Zhu, Jingjing, Zhu, Lixia, Zhou, De, Zheng, Yanlong, Yang, Xiudi, Zhu, Mingyu, Sun, Jianai, Xie, Wanzhuo, Ye, Xiujin
Publicado no PLoS One (2016)

Blood biomarkers in adults with lymph node enlargement contribute to diagnostic significance of malignancy

Por Ma, Shanshan, Guo, Junbin, Lu, Danlei, Zhu, Lixia, Zhou, Meng, Zhou, De, Li, Li, Zhu, Jingjing, Yang, Xiudi, Zheng, Yanlong, Ye, Xiujin, Xie, Wanzhuo
Publicado no Oncotarget (2017)

Clinical and histological features of primary testicular diffuse large B-cell lymphoma: a single center experience in China

Por Zhou, De, Bao, Changqian, Ye, Xiujin, Zhu, Lixia, Zhu, Jingjing, Li, Li, Zhu, Mingyu, Yang, Xiudi, Zheng, Yanlong, Huang, Xianbo, Xie, Mixue, Xie, Wanzhuo
Publicado no Oncotarget (2017)

Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma

Por Xie, Wanzhuo, Hu, Keyue, Xu, Fan, Zhou, De, He, Jingsong, Shi, Jimin, Luo, Yi, Zhu, Jingjing, Zhang, Jie, Lin, Maofang, Ye, Xiujin, Huang, He, Cai, Zhen
Publicado em 2012

Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy

Por XIE, WANZHUO, ZHOU, DE, HU, KEYUE, XIAO, XIBIN, HUANG, WEIJIA, HE, JINSONG, SHI, JIMIN, LUO, YI, ZHANG, JIE, LIN, MAOFANG, CAI, ZHEN, HUANG, HE, YE, XIUJIN
Publicado em 2013

Significance of clinical factors as prognostic indicators for patients with peripheral T-cell non-Hodgkin lymphoma: A retrospective analysis of 252 cases

Por XIE, WANZHUO, HU, KEYUE, XU, FAN, ZHOU, DE, HUANG, WEIJIA, HE, JINGSONG, SHI, JIMIN, LUO, YI, ZHANG, JIE, LIN, MAOFANG, YE, XIUJIN, CAI, ZHEN, HUANG, HE
Publicado em 2013